(Q38356667)

2 September 2017

title

GATA-1 and GATA-2 binding to 3' enhancer of WT1 gene is essential for its transcription in acute leukemia and solid tumor cell lines (English)

1 reference

2 September 2017

1 reference

A Furuhata

1

1 reference

2 September 2017

M Murakami

2

1 reference

2 September 2017

H Ito

3

1 reference

2 September 2017

S Gao

4

1 reference

2 September 2017

K Yoshida

5

1 reference

2 September 2017

S Sobue

6

1 reference

2 September 2017

R Kikuchi

7

1 reference

2 September 2017

T Iwasaki

8

1 reference

2 September 2017

A Takagi

9

1 reference

2 September 2017

T Kojima

10

1 reference

2 September 2017

M Suzuki

11

1 reference

2 September 2017

A Abe

12

1 reference

2 September 2017

T Naoe

13

1 reference

2 September 2017

T Murate

14

1 reference

2 September 2017

publication date

12 February 2009

1 reference

2 September 2017

1 reference

2 September 2017

volume

23

1 reference

2 September 2017

issue

7

1 reference

2 September 2017

page(s)

1270-1277

1 reference

Wilms' tumour gene 1 (WT1) in human neoplasia.

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.13

Alternative splicing and genomic structure of the Wilms tumor gene WT1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.13

WT1 influences apoptosis through transcriptional regulation of Bcl-2 family members

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.13

Antiapoptotic function of 17AA(+)WT1 (Wilms' tumor gene) isoforms on the intrinsic apoptosis pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.13

Wilms' tumor gene 1 (WT1) expression in childhood acute lymphoblastic leukemia: a wide range of WT1 expression levels, its impact on prognosis and minimal residual disease monitoring.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.13

Prognostic impact of RT-PCR-based quantification of WT1 gene expression during MRD monitoring of acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.13

Identification of a gene element essential for leukemia-specific expression of transgenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.13

Possible regulation of Wilms' tumour gene 1 (WT1) expression by the paired box genes PAX2 and PAX8 and by the haematopoietic transcription factor GATA-1 in human acute myeloid leukaemias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.13

PAX 8 regulates human WT1 transcription through a novel DNA binding site

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.13

Transactivation of an intronic hematopoietic-specific enhancer of the human Wilms' tumor 1 gene by GATA-1 and c-Myb

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.13

Roles of hematopoietic transcription factors GATA-1 and GATA-2 in the development of red blood cell lineage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.13

Ewing's sarcoma fusion protein, EWS/Fli-1 and Fli-1 protein induce PLD2 but not PLD1 gene expression by binding to an ETS domain of 5' promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.13

Murine and human T-lymphocyte GATA-3 factors mediate transcription through a cis-regulatory element within the human T-cell receptor delta gene enhancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.13

Impact of laparoscopic cholecystectomy on the management of cholelithiasis in children with sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.13

Pax-2 is a DNA-binding protein expressed in embryonic kidney and Wilms tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.13

Wilms' tumor gene WT1 17AA(-)/KTS(-) isoform induces morphological changes and promotes cell migration and invasion in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.13

7 January 2021

The Wilms' tumor gene WT1 is a good marker for diagnosis of disease progression of myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.13

7 January 2021

A tumor suppressor and oncogene: the WT1 story.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.13

7 January 2021

Sp1 is a critical regulator of the Wilms' tumor-1 gene

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.13

7 January 2021

PAX8-mediated activation of the wt1 tumor suppressor gene

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.13

7 January 2021

Wilms' tumor 1 message and protein expression in bone marrow failure syndrome and acute leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.13

7 January 2021

Quantitative RT-PCR analysis of sphingolipid metabolic enzymes in acute leukemia and myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.13

7 January 2021

Paired box gene expression in Wilms' tumor

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.13

7 January 2021

Very low frequencies of human normal CD34+ haematopoietic progenitor cells express the Wilms' tumour gene WT1 at levels similar to those in leukaemia cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.13

7 January 2021

GATA-1 transcription factor is up-regulated in bone marrow hematopoietic progenitor CD34(+) and erythroid CD71(+) cells in myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.13

7 January 2021

Identifiers

DOI

10.1038/LEU.2009.13

1 reference

Dimensions Publication ID

2 September 2017

1013700289

0 references

1 reference